Roche outlines plans to move towards autonomous AI labs
Roche announced plans to build autonomous AI labs to accelerate drug discovery, aiming to reallocate $2 billion in R&D savings by 2026. The company targets 20 new molecular entities by 2030 with AI dr
reuters · 2026-09-28 04:05 UTC